Gene silencing activity of siRNAs with a ribo-difluorotoluyl nucleotide

J Xia, A Noronha, I Toudjarska, F Li, A Akinc… - ACS chemical …, 2006 - ACS Publications
J Xia, A Noronha, I Toudjarska, F Li, A Akinc, R Braich, M Frank-Kamenetsky, KG Rajeev…
ACS chemical biology, 2006ACS Publications
Recently, chemically synthesized short interfering RNA (siRNA) duplexes have been used
with success for gene silencing. Chemical modification is desired for therapeutic
applications to improve biostability and pharmacokinetic properties; chemical modification
may also provide insight into the mechanism of silencing. siRNA duplexes containing the 2,
4-difluorotoluyl ribonucleoside (rF) were synthesized to evaluate the effect of noncanonical
nucleoside mimetics on RNA interference. 5′-Modification of the guide strand with rF did …
Recently, chemically synthesized short interfering RNA (siRNA) duplexes have been used with success for gene silencing. Chemical modification is desired for therapeutic applications to improve biostability and pharmacokinetic properties; chemical modification may also provide insight into the mechanism of silencing. siRNA duplexes containing the 2,4-difluorotoluyl ribonucleoside (rF) were synthesized to evaluate the effect of noncanonical nucleoside mimetics on RNA interference. 5′-Modification of the guide strand with rF did not alter silencing relative to unmodified control. Internal uridine to rF substitutions were well-tolerated. Thermal melting analysis showed that the base pair between rF and adenosine (A) was destabilizing relative to a uridine-adenosine pair, although it was slightly less destabilizing than other mismatches. The crystal structure of a duplex containing rF∘A pairs showed local structural variations relative to a canonical RNA helix. As the fluorine atoms cannot act as hydrogen bond acceptors and are more hydrophobic than uridine, there was an absence of a well-ordered water structure around the rF residues in both grooves. siRNAs with the rF modification effectively silenced gene expression and offered improved nuclease resistance in serum; therefore, evaluation of this modification in therapeutic siRNAs is warranted.
ACS Publications